{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-14",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20221216",
          "review_priority": "PRIORITY",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "72926",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214907s002lbl.pdf",
              "date": "20221219",
              "type": "Label"
            },
            {
              "id": "72927",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/214907Orig1s002ltr.pdf",
              "date": "20221220",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20211129",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "69422",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/214907Orig1s000ltr.pdf",
              "date": "20211130",
              "type": "Letter"
            },
            {
              "id": "69426",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/214907s000lbl.pdf",
              "date": "20211130",
              "type": "Label"
            },
            {
              "id": "69746",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2021/214907Orig1s000TOC.html",
              "date": "20211222",
              "type": "Review"
            }
          ]
        }
      ],
      "application_number": "NDA214907",
      "sponsor_name": "ON TARGET LABS",
      "openfda": {
        "application_number": [
          "NDA214907"
        ],
        "brand_name": [
          "CYTALUX"
        ],
        "generic_name": [
          "PAFOLACIANINE INJECTION"
        ],
        "manufacturer_name": [
          "On Target Laboratories, Inc."
        ],
        "product_ndc": [
          "81052-138"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "PAFOLACIANINE SODIUM"
        ],
        "spl_id": [
          "4cc23694-63af-f9f1-e063-6394a90a4ce0"
        ],
        "spl_set_id": [
          "d21952b9-7c4e-3a56-e053-2a95a90a0ab0"
        ],
        "package_ndc": [
          "81052-138-01",
          "81052-138-10"
        ],
        "unii": [
          "4HUF3V875C"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "CYTALUX",
          "active_ingredients": [
            {
              "name": "PAFOLACIANINE SODIUM",
              "strength": "EQ 3.2MG BASE/1.6ML (EQ 2MG BASE/ML)"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "SOLUTION",
          "route": "INTRAVENOUS",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}